Literature DB >> 6461109

Transplantation of cultured thymus fragments. III. Induction of allotolerance.

R Hong, R Klopp.   

Abstract

Balb/c nude mice were transplanted with cultured thymic fragments from C57BL/6, hybrid (C57BL/6xC3H F1 or BALB/cxC3H F1) or 2 separate strains simultaneously. Tolerance to H-2 of the thymus donor strain(s) was assessed by skin-graft acceptance and was seen in all cases except where 2 thymuses, each of differing strains, were transplanted simultaneously. Examination of mixed leukocyte culture and cell mediated lympholysis revealed blunted reactivity against thymus donor strains when skin graft tolerance was seen. Demonstration of a suppressor cell population was unsuccessful although a decreased cytotoxic T-cell potential was suggested by decreased GVH activity. These studies showed a unique dependence upon the thymus gland for the phenomenon demonstrated and are taken to be an example of a more generalized process in which effector cell function of the thymus is controlled by intrathymic events during the early maturation of precursor effector cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461109

Source DB:  PubMed          Journal:  Thymus        ISSN: 0165-6090


  3 in total

1.  Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity.

Authors:  Rongfang Wang; Yiran Wang-Zhu; Howard Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

2.  Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly.

Authors:  Ivan K Chinn; Blythe H Devlin; Yi-Ju Li; M Louise Markert
Journal:  Clin Immunol       Date:  2007-12-26       Impact factor: 3.969

Review 3.  Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Stem Cells Transl Med       Date:  2017-01-03       Impact factor: 6.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.